Creative Eye (India) Buy Hold or Sell Recommendation

CREATIVEYE -- India Stock  

INR 2.55  0.20  7.27%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Creative Eye Limited is 'Not Rated'. Macroaxis provides Creative Eye buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CREATIVEYE positions. The advice algorithm takes into account all of Creative Eye Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CREATIVEYE buy-and-hold prospective. Check also Trending Equities.

Time Horizon

Risk Tolerance

Execute Advice
Sell Creative EyeBuy Creative Eye
Not Rated
For the selected time horizon Creative Eye Limited has a risk adjusted performance of 0.10, jensen alpha of 0.28, total risk alpha of 0.09, sortino ratio of 0.0 and treynor ratio of 2.28
We provide buy or sell advice to complement the prevailing expert consensus on Creative Eye Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Creative Eye is not overpriced, please confirm all Creative Eye Limited fundamentals including its Price to Earning, Debt to Equity, Current Liabilities, as well as the relationship between EBITDA and Beta .

Creative Eye Returns Distribution Density

Mean Return0.28Value At Risk5.26
Potential Upside5.56Standard Deviation3.15
 Return Density 

Creative Eye Alerts

Trading Alerts and Improvement Suggestions

Creative Eye Limited is not yet fully synchronised with the market data
The company reported revenue of 76.64 M. Net Loss for the year was (44.27 M) with loss before overhead, payroll, taxes, and interest of (25.43 M).
Check also Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.